Recent advances of novel fourth generation EGFR inhibitors in overcoming C797S mutation of lung cancer therapy
Li Xu, Bing Xu, Jianshe Wang, Yuan Gao, Xingrui He, Tian Xie, Xiang‐Yang Ye
Topics & Concepts
OsimertinibLung cancerEpidermal growth factor receptorMedicineCancer researchCancerGefitinibTyrosine kinaseOncologyEGFR inhibitorsDrug resistancePopulationInternal medicineErlotinibBiologyReceptorGeneticsEnvironmental healthProtein Degradation and InhibitorsLung Cancer Treatments and MutationsCancer therapeutics and mechanisms